Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives $39.86 Consensus Price Target from Brokerages
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have received a consensus rating of “Buy” from the nine ratings firms that are covering the stock, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year price […]
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have received a consensus rating of “Buy” from the nine ratings firms that are covering the stock, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year price […]
